Several studies revealed that CLU/rs11136000 SNP is associated with increased CLU expression but decreased AD risk.[14–17] IJsselstijn et al showed that in presymptomatic AD patients, plasma clusterin was not elevated.[18] These results are in contradiction to the hypothesis that increased plasma clusterin is a protective mechanism. This evidence concerns the gene CLU and Alzheimer disease.